Back to Search
MATTHEW MEYERSON, M.D.
M.D.
Clinical Pathology/Laboratory Medicine Physician
NPI: 1205979697Individual
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
152244(MA)
Research & Publications (20)
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
PMID 19040416·J Cell Mol Med·2009
8-other
Molecular classification and molecular genetics of human lung cancers.
PMID 14981576·Semin Oncol·2004
6-review
High-resolution mapping of copy-number alterations with massively parallel sequencing.
PMID 19043412·Nat Methods·2009
8-other
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
PMID 19470766·Cancer Res·2009
4-observational
Lin28 promotes transformation and is associated with advanced human malignancies.
PMID 19483683·Nat Genet·2009
7-preclinical
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
PMID 18932182·J Pathol·2009
8-other
The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors.
PMID 19136632·Proc Natl Acad Sci U S A·2009
8-other
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR.
PMID 19351834·Cancer Res·2009
8-other
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
PMID 19193619·Clin Cancer Res·2009
8-other
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
PMID 19451690·J Clin Invest·2009
7-preclinical
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
PMID 19261849·Proc Natl Acad Sci U S A·2009
8-other
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
PMID 19156837·Genes Chromosomes Cancer·2009
8-other
Pivotal role of mTOR signaling in hepatocellular carcinoma.
PMID 18929564·Gastroenterology·2008
4-observational
Activating mutations in ALK provide a therapeutic target in neuroblastoma.
PMID 18923525·Nature·2008
7-preclinical
Chromosomal deletions and progression of premalignant lesions: less is more.
PMID 19138986·Cancer Prev Res (Phila)·2008
8-other
Highly parallel identification of essential genes in cancer cells.
PMID 19091943·Proc Natl Acad Sci U S A·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- DANA-FARBER CANCER INSTI, M 430
BOSTON, MA 02115 - Phone
- (617) 632-4768
Quick Facts
- NPI
- 1205979697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile